Press Releases | Arnold Ventures

California Selects Civica Rx as Its Insulin Manufacturing Partner

03.20.2023

New Survey Shows Americans Overwhelmingly Believe Congress and the Biden Administration Should Crack Down on Medicare Advantage Insurers for Abusive Billing Practices

03.20.2023

Statement on the Biden Administration’s Final Regulations to Implement the No Surprises Act

08.19.2022

Statement from Laura and John Arnold on Landmark Law to Lower Prescription Drug Prices

08.16.2022

Statement from Laura and John Arnold Following Senate Passage of the Inflation Reduction Act of 2022

08.07.2022

“It’s time to finish the job.”: Statement from Mark E. Miller on Historic Opportunity for Congress to Lower Prescription Drug Prices

06.30.2022

Statement from Mark E. Miller on Medicare Advantage Oversight Hearing

06.27.2022

Statement from Mark E. Miller on New Insulin Legislation Offered in Senate

06.23.2022

Statement from Arnold Ventures’ Mark Miller on Federal Judge’s Ruling on Surprise Billing Arbitration Process

02.24.2022

Arnold Ventures’ Statement on the Removal of Drug Pricing from the Build Back Better Framework

10.28.2021

No Surprises Act Implementation Positive Sign for Patients Hurt By Surprise Bills

10.01.2021

Arnold Ventures’ Statement on Medicare Trustees Report

09.01.2021

Arnold Ventures’ Statement on No Surprises Act Final Rule

07.01.2021

Arnold Ventures’ Statement on the Elijah E. Cummings Lower Drug Costs Now Act

04.22.2021

A Statement from Arnold Ventures on Surprise Medical Billing Legislation

12.22.2020

A Statement From Arnold Ventures on Organ Donation Rules

12.21.2020

Arnold Ventures’ Statement on the Supreme Court Ruling on Trump v. Commonwealth of Pennsylvania

07.08.2020

Arnold Ventures Submits Public Comment on Proposed Organ Donation Rule

02.21.2020

John Arnold Statement on the Passage of HR 3, Lower Drug Costs Now Act of 2019

12.12.2019

Manatt and Arnold Ventures Release Opioid Toolkit for State Medicaid Leaders

11.12.2019

Arnold Ventures Announces National Program to Expand Opioid Treatment in Jails

05.09.2019

Introducing “Deep Dive with Laura Arnold,” an issues-based podcast from Arnold Ventures

04.30.2019

Arnold Ventures Statement on Energy and Commerce Committee Passage of Six Drug Pricing Bills

04.04.2019

Arnold Ventures’ Mark Miller Testifies Before Senate Committee on Finance

01.30.2019

Grants

Arnold Ventures funds projects to understand problems and identify policy solutions.

See All Grants